Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery

NCT05169866 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

274

Enrollment

OTHER

Sponsor class

Conditions

New Onset Atrial Fibrillation
Complications; Cardiac, Postoperative

Interventions

DRUG: Nifekalant
DRUG: Amiodarone

Sponsor

Beijing Anzhen Hospital